4-(2-aminoethyl)-6-chloro-7-hydroxy-2H-chromen-2-one methanesulfonate

Catalog No. :
ACMOLN386
CAS No. :
1883548-92-2
Molecular Formula :
C12H14ClNO6S
Molecular Weight :
335.77

IUPAC Name:4-(2-aminoethyl)-6-chloro-7-hydroxy-2H-chromen-2-one methanesulfonate

4-(2-aminoethyl)-6-chloro-7-hydroxy-2H-chromen-2-one methanesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$64.00Login to see priceInquiryInquiry
5mg98%$148.00Login to see priceInquiryInquiry
10mg98%$222.00Login to see priceInquiryInquiry
25mg98%$379.00Login to see priceInquiryInquiry
50mg98%$552.00Login to see priceInquiryInquiry
100mg98%$786.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-aminoethyl)-6-chloro-7-hydroxy-2H-chromen-2-one methanesulfonate
IUPAC Name4-(2-aminoethyl)-6-chloro-7-hydroxy-2H-chromen-2-one methanesulfonate
Molecular FormulaC12H14ClNO6S
Molecular Weight335.77
SMILESCS(=O)(=O)O.NCCC1=CC(=O)OC2=CC(O)=C(Cl)C=C12
InChI KeyZEZDFYRVIVZPAT-UHFFFAOYSA-N
Synonym4-(2-Aminoethyl)-6-chloro-7-hydroxy-2H-1-benzopyran-2-one methanesulfonate
CAS No.1883548-92-2
PubChem CID91691121

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMOLN386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMOLN386 route product structure diagram
    ACMOLN3861883548-92-2
Inquiry

2. ACMOLN386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMOLN386 route product structure diagram
    ACMOLN3861883548-92-2
Inquiry

Comments (0)